BioNJ Announces Lineup for BioPartnering Conference [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Morgan Johnson & Johnson and Morgan Lewis and hosted by Jersey City Economic Development Corp ., the Conference will bring together life sciences executives, investors, strategics, academic collaborators and business development professionals for 1-1 partnering, Industry Connections (office hours with large biopharma companies), exhibits, company pitch presentations, plenary sessions and lots of networking -- including a closing networking reception. The action-packed schedule is designed to create meaningful opportunities, grow the ecosystem and bolster medical innovation. Timely plenary sessions will include: Industry Overview: Key Trends & Outlook BioPartnering: Keys to Success for Biotech and Pharma Partnerships How Biopharma Companies are Using AI to Accelerate Innovation Venture Capital's New Era: Dynamic Shifts and Future Trends And, featuring thought leaders , such as: Tyler Bryk , Head of Artificial Intelligence, PTC Therapeutics Samuele Butera , President, U.
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Celonis Appoints Mark Jacobs as Go-to-Market Leader for North America [Yahoo! Finance]Yahoo! Finance
- Phase 2 data for ERLEADA® ?(apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer shows 100 percent biochemical free recurrence rate more than two years post-surgery [Yahoo! FinYahoo! Fin
- Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery [Yahoo! Finance]Yahoo! Finance
- TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
- TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/3/24 - Form 4
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- JNJ's page on the SEC website